on Lyell Immunopharma Inc. (NASDAQ: LYEL) stock is up on Monday as the company is providing an update on the safety profile ...

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival ...

Colon cancer symptoms in women are similar to those in men, but they can be confused with gynecological issues, like cramping ...

Colorectal cancer is one of the most common types of tumor and is responsible for around 10% of cancer-related deaths worldwide. The tumor is particularly dangerous when it forms metastases—i.e.

"ASCO 2026: Interim data released for upcoming BRAF and RAS mCRC therapies" was originally created and published by Clinical ...

Significant reductions seen in non-small cell lung cancer, breast cancer, colorectal cancer, and hepatocellular carcinoma.

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) announced Wednesday that it has successfully completed the Phase 1a ...

Natera (NasdaqGS:NTRA) is expanding its oncology footprint through a CytoDyn partnership focused on real-world ctDNA insights in metastatic colorectal cancer. The company also partnered with Diakonos ...

A Cleveland Clinic study finds Ozempic-style GLP-1 drugs may significantly slow the spread of several obesity-related cancers ...

A growing body of evidence suggests that popular GLP-1 drugs, widely used for weight loss and diabetes, can provide ...